`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC. and MYLAN LABORATORIES
`LIMITED,
`Petitioner,
`
`v.
`
`UCB PHARMA GMBH,
`Patent Owner.
`
`Case IPR2016-00510
`Patent 6,858,650 B1
`
`
`
`
`
`PATENT OWNER POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2016-00510
`Patent 6,858,650 B1
`
`PATENT OWNER POWER OF ATTORNEY
`
`Patent Owner, UCB Pharma GmbH, hereby appoints the following as its attorneys to
`
`transact all business in the United States Patent & Trademark Office associated with the above-
`
`captioned inter partes review:
`
`Jeffrey J. Oelke (Reg. No. 37,409), having a postal, email and hand-delivery address of:
`
`White & Case LLP
`1155 Avenue of the Americas
`New York, New York 10036
`Telephone: (212) 819-8200
`joelke@whitecase.com
`
`
`
`
`
`
`
`James S. Trainor, Jr. (Reg. No. 52,297), having a postal, email and hand-delivery address of:
`
`White & Case LLP
`1155 Avenue of the Americas
`New York, New York 10036
`Telephone: (212) 819-8200
`jtrainor@whitecase.com
`
`
`
`
`
`
`
`Robert E. Counihan (Reg. No. 61,382), having a postal, email and hand-delivery address of:
`
`White & Case LLP
`1155 Avenue of the Americas
`New York, New York 10036
`Telephone: (212) 819-8200
`rcounihan@whitecase.com
`
`
`
`
`
`
`
`and all other practitioners working in conjunction with the aforementioned attorneys.
`
`
`
`
`
`
`
`
`2
`
`
`
`
`
`
`
`IPR2016-00510
`Patent 6,858,650 B1
`The individual signing below has the authority to execute this document on behalf of
`
`UCB Pharma GmbH.
`
`/Eric Schemann/ (Electronically signed)______
`[SIGNATURE]
`
`Eric Schemann__________________________
`[BY]
`
`Managing Director_______________________
`[TITLE]
`
`02/18/16_______________________________
`[DATE]
`
`
`
`
`
`
`3